Clinical Trial Update: Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating short-course radiation followed by mFOLFOX-6 plus COMPOUND 2055269 for locally advanced rectal adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• COMPOUND 2055269
• mFOLFOX-6

Snippet

Sponsor: Ali Shamseddine | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: UNKNOWN